维普中文期刊产品整合服务
77篇 您的检索式:作者名="Marbury"
    题名 作者 年代 出处 被引量
1马伯里诉麦迪逊显示文摘1803年2月24日,首席大法官马歇尔发表了如下意见: 在书记员宣读宣誓书(affidavits)并归档之后,此案形成了一个规则,即要求国务卿说明不送达命令状(mandams)的理由,并命令他给威廉·马伯里颁发哥伦比亚地区华盛顿特区治安法官(a justice of the peace)的委任状。Marbury v.Madison 黎军(译者) 2000中外法学2000,12,2:6
2A randomized,doubleblind,multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis显示文摘Cox CE Marbury TC Pittman WG 2002Clinical therapeutics2002,24,2:1
3Quadriceps tendon rup- tures in uremia显示文摘Bhole R Flynn JC Marbury TC 1985Clin Orthop Relat Res1985,,195:1
4Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment显示文摘Zhou XJ Marbury TC Alcorn HW et a1 2006Antimicrob Agents Chemother2006,50,5:1
5A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients显示文摘 Clauson P Marbury TC 1999Diabetes Care1999,22,:1
6Antihypertensive efficacy and safety of olmesartan medoxomil compered with amlodipine for mild-to-moderate hypertension显示文摘Chrysant S G Marbury T C Robinson T D 2003J Hum Hyperten2003,17,6:1
7Pharmaeokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease,and volunteers with renal dysfunction显示文摘Hebert MF Smith HE Marbury TC 2005J Clin Pharmacol2005,45,:1
8Inhibition of estradiol synthesis attenuates renal injury inmale streptozotocin-induced diabetic rats显示文摘Manigrasso MB Sawyer RT Marbury DC 2011Am JPhysiol Renal Physiol2011,301,3:1
9A double-blind randomized comparison of meal-related glycemic control by repaglinide and glibenclimide in well controled type 2 diabetic patient显示文摘DAMSBO P CLAUSON P MARBURY T C 1999Diabetes Care1999,22,5:1
10A randomized, double - blind,multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis显示文摘 Marbury TC Pittman WG 2002Clin Ther2002,24,2:1
11Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension显示文摘CHRYSANT SG MARBURY TC ROBINSON TD 2003J Hum Hypertension2003,17,6:1
12Anaritide in acute tubular necrosis显示文摘Allgren RL Marbury TC Noor RS 1997N Engl J Med1997,336,:1
13A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients 显示文摘Damsbo P Clauson P Marbury TC 1999Diabetes Care1999,22,5:1
14A randomised, double-blind, muhcenter comparison of gatifloxaeinversus ciprofloxacin in the treatment of complicated urinary tract infection and pylonopritis显示文摘Cox C E Marbury T C Pittman W G etal 2002Clin Ther2002,24,:1
15Single-dose pharmacokinetics of sustained-release fampridine (fampridine-SR) in healthy volunteers and adults with renal impairment显示文摘Smith W Swan S Marbury T 0,,02:1
16Phar- macokinetics, pharmaco- dynamics, and safety of cle- vidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension 显示文摘Smith WB Marbury TC Komjathy SF 2012Eur J Clin Phannacol2012,68,10:1
17A randomized, doubleblind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis显示文摘Cox CE Marbury TC Pittman WG 2002Clin Ther2002,24,2:1
18A randomized , double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonepritis显示文摘 Marbury TC Pittman WG 2002Clin Ther2002,24,:1
19A double blind randomised comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients显示文摘Damsbo P Clauson P Marbury TC 1999Diabetes Care1999,22,5:1
20Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlosartan medoxomil compared with amlodipine for mild-to-moderate hypertension 显示文摘Chrysant SG Marbury TC 2003Journal of Hu- man Hypertension2003,17,6:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费